Add-on Acquisition • Life Science

Adare Pharma Solutions Acquires Frontida

On December 1, 2021, Adare Pharma Solutions acquired life science company Frontida

Acquisition Context
  • This is Adare Pharma Solutions’ 2nd transaction in the Life Science sector.
  • This is Adare Pharma Solutions’ 3rd transaction in the United States.
  • This is Adare Pharma Solutions’ 2nd transaction in Pennsylvania.

Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date December 1, 2021
Target Frontida
Sector Life Science
Buyer(s) Adare Pharma Solutions
Deal Type Add-on Acquisition

Target Company

Frontida

Philadelphia, Pennsylvania, United States
Frontida is a vertically integrated CDMO focused on oral formulations. Frontida's broad spectrum of manufacturing equipment and know-how provide innovative solutions for everything from traditional proprietary technologies, clinical trial materials, and commercial production goods. Frontida BioPharm was founded in 2016 and is based in Philadelphia, Pennsylvania.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Adare Pharma Solutions

Lawrenceville, New Jersey, United States

Category Company
Founded 2015
Sector Life Science
DESCRIPTION

Adare Pharma Solutions provides enhanced medicines, creating new possibilities for improved patient health. Adare Pharma Solutions has solved complex formulation, manufacturing, and commercialization challenges, resulting in transformational medicines that deliver value to all its stakeholders. The company has a global presence with R&D, manufacturing, and commercial operations in the Unites States, Europe, and Canada. Adare Pharma Solutions was founded in 2015 and is based in Lawrenceville, New Jersey.


Deal Context for Buyer #
Overall 3 of 3
Sector: Life Science 2 of 2
Type: Add-on Acquisition 2 of 2
State: Pennsylvania 2 of 2
Country: United States 3 of 3
Year: 2021 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-18 Viactiv

Greenwich, Connecticut, United States

Viactiv line of supplement chews for bone health, immune health and other applications. Currently marketed through many retailers, including, among others, Walmart (retail and online), Target and Amazon, the Viactiv product lines are expected to become Guardion’s most prominent product lines, as well as to provide access to significant opportunities in the short-term for growth and expansion. Viactiv is based in Greenwich, Connecticut.

Sell -